Nogapendekin-alfa Inbakicept

· ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Nogapendekin-alfa Inbakicept, covering 2025-10-14 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer [Phase 3]